Evidence map›Paper›PMID 38705262›Full record

ReviewPharmacological research2024

Tracking progress on antimicrobial resistance by the quadripartite country self-assessment survey (TrACSS) in G7 countries, 2017-2023: opportunities and gaps.

Michela Sabbatucci, Diane Ashiru-Oredope, Laura Barbier, Elisa Bohin, Sabine Bou-Antoun, Colin Brown, Alexandra Clarici, Claire Fuentes, Takahiro Goto, Francesco Maraglino and 8 more

Abstract readReview
In one paragraph

Review in Pharmacological research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Probiotics and postbiotics to counter antimicrobial resistant infections, an editorial.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. First record of methicillin-resistantNew microbes and new infections · 2025
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Michela SabbatucciDirectorate General Health Prevention, Communicable Diseases and International Prophylaxis, Ministry of Health, Rome 00144, Italy. Electronic address: michela.sabbatucci@iss.it.
Diane Ashiru-OredopeHCAI, Fungal, AMR, AMU & Sepsis Division, United Kingdom Health Security Agency, London NW9 5EQ, United Kingdom; NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, United Kingdom. Electronic address: diane.ashiru-oredope@ukhsa.gov.uk.
Laura BarbierFrench Ministry of Ecological Transition and Territorial Cohesion, La Défense 92055, France. Electronic address: laura.barbier@developpement-durable.gouv.fr.
Elisa BohinFrench Ministry of Agriculture and Food Sovereignty, Paris 75015, France. Electronic address: elisa.bohin@agriculture.gouv.fr.
Sabine Bou-AntounHCAI, Fungal, AMR, AMU & Sepsis Division, United Kingdom Health Security Agency, London NW9 5EQ, United Kingdom. Electronic address: Sabine.BouAntoun@ukhsa.gov.uk.
Colin BrownHCAI, Fungal, AMR, AMU & Sepsis Division, United Kingdom Health Security Agency, London NW9 5EQ, United Kingdom; NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, United Kingdom. Electronic address: colin.brown@ukhsa.gov.uk.
Alexandra ClariciFederal Ministry of Health, Division "One Health, Antimicrobial Resistance", Berlin 10117, Germany. Electronic address: alexandra.clarici@bmg.bund.de.
Claire FuentesFrench Ministry of Agriculture and Food Sovereignty, Paris 75015, France. Electronic address: claire.fuentes@agriculture.gouv.fr.
Takahiro GotoInternational Affairs Division, Minister's Secretariat, Ministry of Health, Labour and Welfare, Tokyo 100-8916, Japan. Electronic address: gotou-takahiro@mhlw.go.jp.
Francesco MaraglinoDirectorate General Health Prevention, Communicable Diseases and International Prophylaxis, Ministry of Health, Rome 00144, Italy. Electronic address: f.maraglino@sanita.it.
Julien MorinFrench Ministry of Health and Prevention, Paris 75007, France. Electronic address: julien.morin@sante.gouv.fr.
Ines RönnefahrtFederal Ministry for the Environment, Nature Conservation, Nuclear Safety and Consumer Protection, Division "Plant Protection Products, Biocides, Medicinal Products", Berlin 10117, Germany. Electronic address: ines.roennefahrt@bmuv.bund.de.
Andrea SanwidiFederal Ministry of Food and Agriculture, Division "Veterinary medicines, residues of pharmacologically active substances in food", Bonn 53123, Germany. Electronic address: andrea.sanwidi@bmel.bund.de.
Carry Triggs-HodgeHCAI, Fungal, AMR, AMU & Sepsis Division, United Kingdom Health Security Agency, London NW9 5EQ, United Kingdom. Electronic address: carry.triggshodge@ukhsa.gov.uk.
Antonio VitielloDirectorate General Health Prevention, Communicable Diseases and International Prophylaxis, Ministry of Health, Rome 00144, Italy. Electronic address: a.vitiello@sanita.it.
Andrea ZoviDirectorate General for Hygiene, Food Safety and Nutrition, Ministry of Health, Rome 00144, Italy. Electronic address: a.zovi@sanita.it.
Marcello GelorminiControl of Antimicrobial Resistance Programme, World Health Organization Regional Office for Europe, Copenhagen, Denmark. Electronic address: gelorminim@who.int.
Danilo Lo Fo WongControl of Antimicrobial Resistance Programme, World Health Organization Regional Office for Europe, Copenhagen, Denmark. Electronic address: lofowongd@who.int.

Funding

World Health Organization 001
6 · The paper itself

Abstract

Antimicrobial resistance (AMR) poses serious challenges to the healthcare systems worldwide. Multiple factors and activities contribute to the development and spread of antimicrobial-resistant microorganisms. Monitoring progress in combating AMR is fundamental at both global and national levels to drive multisectoral actions, identify priorities, and coordinate strategies. Since 2017, the World Health Organization (WHO) has collected data through the Tracking AMR Country Self-Assessment Survey (TrACSS). TrACSS data are published in a publicly-available database. In 2023, 71 (59.9%) out of 177 responding countries reported the existence of a monitoring and evaluation plan for their National Action Plan (NAP) on AMR, and just 20 countries (11.3%) the allocation of funding to support NAP implementation. Countries reported challenges including limited financial and human resources, lack of technical capacity, and variable political commitment. Even across the Group of Seven (G7) countries, which represent some of the world's most advanced economies, many areas still need improvement, such as full implementation of infection prevention and control measures, adoption of WHO access/watch/reserve (AWaRe) classification of antibiotics, effective integration of laboratories in AMR surveillance in the animal health and food safety sectors, training and education, good manufacturing and hygiene practices in food processing, optimising pesticides use and environmental residues of antimicrobial drugs. Continuous and coordinated efforts are needed to strengthen multisectoral engagement to fight AMR.

Indexed as

World Health OrganizationAnimalsAnti-Bacterial AgentsDrug Resistance, BacterialGlobal HealthHumansSelf-AssessmentSurveys and QuestionnairesAnti-Bacterial AgentsantibioticsAntimicrobial resistanceG7Tracking AMR country self-assessment surveyTrACSS

Identifiers

PMID38705262
PMCPMC11156590

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.